News

Public · Published

WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter

WELL Health and HEALWELL AI said the Commissioner of Competition concluded the Competition Bureau's review of WELL's acquisition of a majority interest in HEALWELL and issued a No Action Letter on October 22, 2026.

Published:

Updated:

What happened

WELL Health and HEALWELL AI said the Commissioner of Competition concluded the Competition Bureau's review of WELL's acquisition of a majority interest in HEALWELL and issued a No Action Letter on October 22, 2026.

Confirmed

Global impact / market context

The letter removes a regulatory cloud over WELL's controlling stake in HEALWELL, completed April 1, 2025, and HEALWELL's purchase of Orion Health. Without a court challenge, the combined businesses can focus on integrating operations instead of defending the deal.

Analyst inference

The Bureau had obtained a Federal Court order in December 2025 for records on the transaction, so the review was active rather than routine. A No Action Letter signals the Commissioner does not currently plan to challenge the deal, reducing uncertainty for holders of both companies.

Analyst inference

What to watch

  1. The No Action Letter, issued October 22, 2026, confirms the Commissioner does not, at this time, intend to make an application under section 92 of the Competition Act regarding the transaction. Confirmed
  2. Watch whether the two companies disclose integration plans and combined cost or revenue figures now that the review is closed, since those details would show how the deal affects spending and profit. Analyst inference
  3. Investors could track future Competition Bureau statements for any change in position, because the letter reflects current intent and does not permanently bar a later challenge under the Competition Act. Proposed

Evidence